Syndicate This week's upcoming IPO's and secondary offerings

Week of July 6 to July 10, 2024

This Day's Priced Deals: July 7th, 2020

Symbol

Issuer

Type

Price

Managers

VERB

VERB Technology
VERB Technology
Secondary
Priced: $1.29
7.75M
Ladenburg

Pricing after close

Managers: Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ARE

Alexandria Real Estate
Alexandria Real Estate
Spot Secondary
Priced: $160.50
5M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, BofA, Goldman Sachs & JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

07/06 - Monday

Symbol

Issuer

Type

Price

Managers

VERB

VERB Technology
VERB Technology
Secondary
Priced: $1.29
7.75M
Ladenburg

Pricing after close

Managers: Ladenburg

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ARE

Alexandria Real Estate
Alexandria Real Estate
Spot Secondary
Priced: $160.50
5M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, BofA, Goldman Sachs & JPMorgan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

07/07 - Tuesday

Symbol

Issuer

Type

Price

Managers

BLCT

BlueCity
BlueCity
IPO
Priced: $16.00
5.3M
AMTD,...

Pricing after close
Deal analysis and details

Managers: AMTD, Loop Capital, Tigress Financial, Prime Number, LAFT

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AKRO

Akero Therapeutics
Akero Therapeutics
Secondary
Priced: $36.00
5.23M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Morgan Stanley, Jefferies & Evercore ISI

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ASND

Ascendis Pharma
Ascendis Pharma
Secondary
Priced: $142.00
4.225M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Morgan Stanley, Evercore ISI & Leerink

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ETNB

89bio
89bio
Secondary
Priced: $27.50
2.6M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Leerink, RBC Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
VIR

Vir Biotechnology
Vir Biotechnology
Secondary
Priced: $42.00
7.14M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, BofA, TD Cowen & Barclays, Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

07/08 - Wednesday

Symbol

Issuer

Type

Price

Managers

HQY

HealthEquity
HealthEquity
Secondary
Priced: $56.00
4.6M
Wells Fargo & JPMorgan,...

Pricing after close
Deal analysis and details

Managers: Wells Fargo & JPMorgan, Goldman Sachs, RBC Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PING

Ping Identity
Ping Identity
Secondary
Priced: $32.00
8.98M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, BofA, RBC Capital & Citi

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RVMD

Revolution Medicines
Revolution Medicines
Secondary
Priced: $26.00
6M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, TD Cowen, Leerink & Guggenheim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OTIC

Otonomy
Otonomy
Spot Secondary
Priced: $3.25
14.5M
TD Cowen,...

Pricing after close
Deal analysis and details

Managers: TD Cowen, Piper Sandler & Cantor Fitzgerald

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TPB

Turning Point Brands
Turning Point Brands
Spot Secondary
Priced: $23.50
2M
TD Cowen

Pricing after close
Deal analysis and details

Managers: TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

07/09 - Thursday

Symbol

Issuer

Type

Price

Managers

IVA

Inventiva
Inventiva
IPO
Priced: $14.40
7.478M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, Stifel & Guggenheim, WAIN, Roth MKM, KBC Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
NKTX

Nkarta
Nkarta
IPO
Priced: $18.00
14M
TD Cowen,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: TD Cowen, Evercore ISI, Stifel & Mizuho

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PSTX

Poseida Therapeutics
Poseida Therapeutics
IPO
Priced: $16.00
14M
BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA, Piper Sandler & William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
CNTG

Centogene
Centogene
Secondary
Priced: $14.00
3.5M
Credit Suisse & Leerink,...

Pricing after close
Deal analysis and details

Managers: Credit Suisse & Leerink, Baird, BTIG, Kempen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access